This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Intrexon Actobiotics N.v., Actogenix N.v.. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: The Innovations of Erik Remaut
Introduction
Erik Remaut is a notable inventor based in Vinderhoute, Belgium. He has made significant contributions to the field of biotechnology, particularly in the preservation of Lactococcus strains. With a total of three patents to his name, his work focuses on enhancing the characteristics of these strains for better preservation and tolerance.
Latest Patents
One of Erik Remaut's latest patents is a method to improve Lactococcus preservation. This patent discloses strains with improved preservation characteristics, as well as enhanced acid and bile salt tolerance. Specifically, it involves a strain that contains a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene. This genetic modification results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. The patent also specifies a strain that has an internal trehalose concentration of at least 10 mg per gram of cells (w/w).
Career Highlights
Throughout his career, Erik Remaut has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Intrexon Actobiotics N.V. and Actogenix N.V. His work in these organizations has contributed to advancements in microbial preservation techniques.
Collaborations
Erik has collaborated with various professionals in his field, including Dirk Iserentant. These collaborations have further enhanced his research and development efforts.
Conclusion
Erik Remaut's innovative work in the preservation of Lactococcus strains showcases his expertise and dedication to biotechnology. His patents reflect significant advancements that could have a lasting impact on the industry.